Global Cell Lysis/Cell Fractionation Market: Overview
Cell fractionation is the process of separating cellular components while at the same time, retaining the individual functions of each component. Similarly, cell lysis is the breaking down of the cell membrane by enzymic, viral, or osmotic mechanisms. Cell lysis/cell fractionation enables scientists to carefully study the different parts of a cell in isolation so as to determine their biochemical composition and function. Much of what scientists know of the molecular biology of a cell is discovered by scrutinizing cell-free systems. The rapid growth of the healthcare, life sciences, and pharmaceutical industries has spurred research and development activities in countless fields, increasing the demand for cell lysis/cell fractionation in laboratories.
The key product types of cell lysis/cell fractionation are reagents and kits, consumables, disposables, beads, and instruments. Instruments such as homogenizers and sonicators are used for cell lysis/cell fractionation. In addition, the various reagents and kits used for cell lysis are detergent solutions, enzymes, and others. The major types of cells that can undergo cell fractionation are microbial cells, mammalian cells, and others. Biopharmaceutical and biotechnology companies and research laboratories and institutes are the prominent end users of cell lysis. The regions studied under the global cell lysis/cell fractionation market are North America, Asia Pacific, Europe, and Rest of the World.
The report carefully studies the different applications, technologies, products, and regional segments of the cell lysis/cell fractionation market and offers sharp insights on the strengths and weaknesses of each. The market study, backed by thorough research and supported by the latest facts and figures, serves as an ideal tool for all stakeholders of the cell lysis/cell fractionation market. Equipped with this knowledge, players can gain a competitive edge over the rest and devise key business strategies for the profitable future of the company.
Global Cell Lysis/Cell Fractionation Market: Key Trends and Opportunities
The global market for cell lysis/cell fractionation is propelled by the high prevalence of diseases, the rise in government funding for research and development activities, the growing focus on personalized medicine, and the expansion of biopharmaceutical and biotechnology industries. Emerging countries are forecast to present high-growth opportunities for players within the cell lysis/cell fractionation market. By contrast, the shortage of skilled personnel, the high cost of cell-based research, and the survival of new entrants and small players are some of the leading impediments.
Consumables form the largest product segment in the cell lysis/cell fractionation market, driven primarily by the rise in cell-based research funding and the increased prevalence of diseases. Mammalian cells are the most commonly fractionated cell types thanks to surging investments by companies and governments for cell-based research and the growing prevalence of diseases such as HIV/AIDS and cancer. Cell lysis/cell fractionation is mostly carried out by research laboratories and institutes such as the National Institutes of Health (NIH).
Global Cell Lysis/Cell Fractionation Market: Region-wise Outlook
Among the key regional segments of the global cell lysis/cell fractionation market, North America holds the largest share, driven by the surging government funding in most countries and the rise of the aging population. This region is anticipated to retain its lead throughout the forecast period. Asia Pacific, on the other hand, is projected to witness the fastest growth in the coming years, particularly in India and China. Europe is also a strong contender in the cell lysis/cell fractionation market.
The most prominent players operating in the global cell lysis/cell fractionation market include Beckman Coulter, Inc., Qiagen N.V., Merck KGAA, Miltenyi Biotec, Cell Signaling Technology, Inc., Qsonica, LLC, Thermo Fisher Scientific, Inc., Roche Diagnostics, Becton, Dickinson and Company, and Bio-Rad Laboratories, Inc.
This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Middle East and Africa
- Latin America
This report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Reasons for Buying this Report
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a six-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
- It provides distinctive graphics and exemplified SWOT analysis of major market segments
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.